On the public citation graph
Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development
0 signed · 415 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1006/mpat.2000.0404openalex-snapshot
Genetic organization of the she pathogenicity island in Shigella flexneri 2a
inferredcites →https://doi.org/10.1016/0264-410x(90)90094-3openalex-snapshot
Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease
inferredcites →https://doi.org/10.1016/0264-410x(95)00102-7openalex-snapshot
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity
inferredcites →https://doi.org/10.1016/0264-410x(96)00006-0openalex-snapshot
Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection
inferredcites →https://doi.org/10.1016/j.carres.2011.02.013openalex-snapshot
Structural elucidation of the O-antigen of the Shigella flexneri provisional serotype 88-893: structural and serological similarities with S. flexneri provisional serotype Y394 (1c)
inferredcites →https://doi.org/10.1016/j.vaccine.2006.03.039openalex-snapshot
Enteric infections and the vaccines to counter them: Future directions
inferredcites →https://doi.org/10.1016/j.vaccine.2009.12.050openalex-snapshot
Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children
inferredcites →https://doi.org/10.1016/s0140-6736(13)60844-2openalex-snapshot
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
inferredcites →https://doi.org/10.1016/s0140-6736(96)06255-1openalex-snapshot
Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults
inferredcites →https://doi.org/10.1038/nrgastro.2013.12openalex-snapshot
Progress and pitfalls in Shigella vaccine research
inferredcites →https://doi.org/10.1038/nrmicro1662openalex-snapshot
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
inferredcites →https://doi.org/10.1056/nejm199111143252006openalex-snapshot
Diarrheal Disease during Operation Desert Shield
inferredcites →https://doi.org/10.1086/424680openalex-snapshot
Deletion in theShigellaEnterotoxin Genes Further AttenuatesShigella flexneri2a Bearing Guanine Auxotrophy in a Phase 1 Trial of CVD 1204 and CVD 1208
inferredcites →https://doi.org/10.1086/427501openalex-snapshot
Gastroenteritis in US Marines during Operation Iraqi Freedom
inferredcites →https://doi.org/10.1093/cid/cis753openalex-snapshot
The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control Study
inferredcites →https://doi.org/10.1093/cid/cis754openalex-snapshot
Diagnostic Microbiologic Methods in the GEMS-1 Case/Control Study
inferredcites →https://doi.org/10.1093/cid/cis761openalex-snapshot
The Global Enteric Multicenter Study (GEMS): Impetus, Rationale, and Genesis
inferredcites →https://doi.org/10.1093/cid/cis787openalex-snapshot
Some Epidemiologic, Clinical, Microbiologic, and Organizational Assumptions That Influenced the Design and Performance of the Global Enteric Multicenter Study (GEMS)
inferredcites →https://doi.org/10.1093/infdis/122.3.181openalex-snapshot
Epidemic Shiga Bacillus Dysentery in Central America. II. Epidemiologic Studies in 1969
inferredcites →https://doi.org/10.1093/infdis/125.1.12openalex-snapshot
Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection
inferredcites →https://doi.org/10.1093/infdis/132.1.15openalex-snapshot
An Outbreak of Dysentery Caused by Shigella dysenteriae Type 1 on a Coral Island in the Bay of Bengal
inferredcites →https://doi.org/10.1093/infdis/157.5.1068openalex-snapshot
Serum Antibodies to Lipopolysaccharide and Natural Immunity to Shigellosis in an Israeli Military Population
inferredcites →https://doi.org/10.1093/infdis/164.3.533openalex-snapshot
Effect of Prior Infection with Virulent Shigella flexneri 2a on the Resistance of Monkeys to Subsequent Infection with Shigella sonnei
inferredcites →https://doi.org/10.1093/infdis/172.5.1408openalex-snapshot
Prevalence of Shigella Enterotoxin 1 among Shigella Clinical Isolates of Diverse Serotypes
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a116134openalex-snapshot
Epidemiologic Patterns of Acute Diarrhea and Endemic Shigella Infections in Children in a Poor Periurban Setting in Santiago, Chile
inferredcites →https://doi.org/10.1111/j.1365-3156.2006.01723.xopenalex-snapshot
Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of shigella isolated from Andaman Islands, India
inferredcites →https://doi.org/10.1128/aem.19.3.434-437.1970openalex-snapshot
Comparison of Media for Direct Isolation and Transport of Shigellae from Fecal Specimens
inferredcites →https://doi.org/10.1128/iai.06174-11openalex-snapshot
Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins
inferredcites →https://doi.org/10.1128/iai.67.2.782-788.1999openalex-snapshot
Strategy for Cross-Protection among Shigella flexneri Serotypes
inferredcites →https://doi.org/10.1128/iai.67.7.3437-3443.1999openalex-snapshot
Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602
inferredcites →https://doi.org/10.1128/jb.187.2.619-628.2005openalex-snapshot
Evolutionary Genetics of a New Pathogenic Escherichia Species: Escherichia albertii and Related Shigella boydii Strains
inferredcites →https://doi.org/10.1128/jcm.02713-12openalex-snapshot
Quantitative PCR for Detection of Shigella Improves Ascertainment of Shigella Burden in Children with Moderate-to-Severe Diarrhea in Low-Income Countries
inferredcites →https://doi.org/10.1128/jcm.29.2.386-389.1991openalex-snapshot
Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis
inferredcites →https://doi.org/10.1136/gut.40.4.505openalex-snapshot
Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo.
inferredcites →https://doi.org/10.1172/jci117991openalex-snapshot
Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro.
inferredcites →https://doi.org/10.1371/journal.pmed.0030353openalex-snapshot
A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and Microbiology
inferredcites →https://doi.org/10.1371/journal.pntd.0002280openalex-snapshot
Housefly Population Density Correlates with Shigellosis among Children in Mirzapur, Bangladesh: A Time Series Analysis
inferredcites →https://doi.org/10.2307/587237openalex-snapshot
Bulletin of the World Health Organization
inferredcites →https://doi.org/10.2471/blt.12.112433openalex-snapshot
Stockpiling oral cholera vaccine
inferredcites →https://doi.org/10.4049/jimmunol.164.4.2221openalex-snapshot
Production of IFN-γ and IL-10 to Shigella Invasins by Mononuclear Cells from Volunteers Orally Inoculated with a Shiga Toxin-Deleted Shigella dysenteriae Type 1 Strain
inferredcites →https://doi.org/10.4161/hv.4746openalex-snapshot
Safety and Immunogenicity of CVD 1208S, a Live, OralΔguaBA Δsen Δset Shigella flexneri2a Vaccine Grown on Animal-Free Media
inferredcites →https://doi.org/10.4269/ajtmh.1971.20.934openalex-snapshot
Epidemic Shiga-Bacillus Dysentery in Central America
inferredcites →https://doi.org/10.4269/ajtmh.1984.33.1192openalex-snapshot
Epidemic Shiga Bacillus Dysentery in Central Africa
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4896053openalex-extracted
Epidemiology of Shigella Species and Serotypes in Children: Results from the Mal-Ed Study
inferred← citeshttps://doi.org/10.2139/ssrn.5386776openalex-extracted
Incidence and Antimicrobial Resistance of Shigella-Attributable Diarrhea in Young Children: Results from the Multi-Country Enterics for Global Health (EFGH) Shigella Surveillance Study
inferred← citeshttps://doi.org/10.1002/asia.201600819openalex-snapshot
Efficient Iterative Synthesis of O‐Acetylated Tri‐ to Pentadecasaccharides Related to the Lipopolysaccharide of Shigella flexneri Type 3 a through Di‐ and Trisaccharide Glycosyl Donors
inferred← citeshttps://doi.org/10.1002/chem.201600567openalex-snapshot
Detailed Investigation of the Immunodominant Role of O‐Antigen Stoichiometric O‐Acetylation as Revealed by Chemical Synthesis, Immunochemistry, Solution Conformation and STD‐NMR Spectroscopy for Shigella flexneri 3a
inferred← citeshttps://doi.org/10.1007/82_2021_248openalex-snapshot
Shigella-Controlled Human Infection Models: Current and Future Perspectives
inferred← citeshttps://doi.org/10.1007/978-3-030-80068-0_15openalex-snapshot
Bacterial Infections of the Small and Large Intestine
inferred← citeshttps://doi.org/10.1007/978-3-031-64288-3_10openalex-snapshot
Shigellosis: The Road from Multiple Drug-Resistance (MDR) to Vaccine Development
inferred← citeshttps://doi.org/10.1007/978-3-031-86002-7_20openalex-snapshot
The Impact of Antibiotic Resistance Genes in Shigellosis
inferred← citeshttps://doi.org/10.1007/s00203-020-02034-3openalex-snapshot
Shigella sonnei: virulence and antibiotic resistance
inferred← citeshttps://doi.org/10.1007/s00253-021-11295-xopenalex-snapshot
Antimicrobial and anti-biofilm activity of thymoquinone against Shigella flexneri
inferred← citeshttps://doi.org/10.1007/s00253-021-11701-4openalex-snapshot
Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system
inferred← citeshttps://doi.org/10.1007/s10989-018-9698-5openalex-snapshot
Designing a Novel Multi-epitope Peptide Vaccine Against Pathogenic Shigella spp. Based Immunoinformatics Approaches
inferred← citeshttps://doi.org/10.1007/s12029-019-00301-1openalex-snapshot
Effects of Curcumin and Silymarin on the Shigella dysenteriae and Campylobacter jejuni In vitro
inferred← citeshttps://doi.org/10.1007/s12088-025-01515-7openalex-snapshot
Deciphering Distinct Pathogenetic Strategies Employed by Shigella Serotypes Using Human Intestinal Organoids
inferred← citeshttps://doi.org/10.1007/s12551-021-00791-zopenalex-snapshot
Glycoconjugate vaccines against Salmonella enterica serovars and Shigella species: existing and emerging methods for their analysis
inferred← citeshttps://doi.org/10.1007/s13205-022-03325-wopenalex-snapshot
Structural chemistry and molecular-level interactome reveals histidine kinase EvgS to subvert both antimicrobial resistance and virulence in Shigella flexneri 2a str. 301
inferred← citeshttps://doi.org/10.1007/s40475-018-0146-6openalex-snapshot
The Epidemiology of Diarrhea in Children Under 5 Years of Age in Mozambique
inferred← citeshttps://doi.org/10.1016/b978-0-12-811924-2.00030-4openalex-snapshot
Oral Shigella Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-12-820954-7.00007-4openalex-snapshot
NMR characterization of bacterial glycans and glycoconjugate vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-12-822850-0.00004-1openalex-snapshot
Nanoparticles in biosensor development for the detection of pathogenic bacteria in water
inferred← citeshttps://doi.org/10.1016/b978-0-323-55512-8.00022-3openalex-snapshot
Approach to the Patient With Diarrhea
inferred← citeshttps://doi.org/10.1016/b978-0-323-75608-2.00057-4openalex-snapshot
Inflammatory Enterocolitis
inferred← citeshttps://doi.org/10.1016/b978-0-323-85730-7.00023-0openalex-snapshot
Mechanisms of gastrointestinal pathogenesis and landscape of intestinal immunity
inferred← citeshttps://doi.org/10.1016/b978-0-323-99886-4.00020-xopenalex-snapshot
The phylogenomics of Shigella spp.
inferred← citeshttps://doi.org/10.1016/b978-84-9113-949-2.00110-4openalex-snapshot
10.1016/b978-84-9113-949-2.00110-4
inferred← citeshttps://doi.org/10.1016/j.cmi.2014.10.019openalex-snapshot
Shift in serotype distribution of Shigella species in China, 2003–2013
inferred← citeshttps://doi.org/10.1016/j.cmi.2018.06.023openalex-snapshot
Update on vaccines for enteric pathogens
inferred← citeshttps://doi.org/10.1016/j.cmi.2022.10.011openalex-snapshot
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data
inferred← citeshttps://doi.org/10.1016/j.ebiom.2017.07.013openalex-snapshot
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe
inferred← citeshttps://doi.org/10.1016/j.eclinm.2021.101076openalex-snapshot
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
inferred← citeshttps://doi.org/10.1016/j.eimc.2014.11.001openalex-snapshot
Shigelosis, la importancia de la higiene en la prevención
inferred← citeshttps://doi.org/10.1016/j.eimc.2015.06.015openalex-snapshot
Enteropatógenos y antibióticos
inferred← citeshttps://doi.org/10.1016/j.eimce.2015.06.002openalex-snapshot
Enteropathogens and antibiotics
inferred← citeshttps://doi.org/10.1016/j.foodcont.2018.07.011openalex-snapshot
Antibacterial activity of gallic acid against Shigella flexneri and its effect on biofilm formation by repressing mdoH gene expression
inferred← citeshttps://doi.org/10.1016/j.genrep.2024.102011openalex-snapshot
Mechanisms of resistance and decreased susceptibility to azithromycin in Shigella
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2018.02.005openalex-snapshot
Antibiotic resistance and molecular characterization of shigella isolates recovered from children aged less than 5 years in Manhiça, Southern Mozambique
inferred← citeshttps://doi.org/10.1016/j.ijid.2019.02.031openalex-snapshot
Burden and risk factors of Shigella sonnei shigellosis among children aged 0–59 months in hyperendemic communities in Israel
inferred← citeshttps://doi.org/10.1016/j.ijmm.2015.04.005openalex-snapshot
Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru)
inferred← citeshttps://doi.org/10.1016/j.ijmm.2015.12.003openalex-snapshot
Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations
inferred← citeshttps://doi.org/10.1016/j.imj.2022.07.002openalex-snapshot
A global overview of the most important zoonotic bacteria pathogens transmitted from Rattus norvegicus to humans in urban environments
inferred← citeshttps://doi.org/10.1016/j.imj.2026.100268openalex-snapshot
Global distribution and genomic characteristics of Shigella: A genomic epidemiological study
inferred← citeshttps://doi.org/10.1016/j.jep.2021.114406openalex-snapshot
Antibacterial and antishigellosis activity of Xylopia staudtii (engl. & diels), Annonaceae
inferred← citeshttps://doi.org/10.1016/j.jgar.2016.12.009openalex-snapshot
First report on whole-genome shotgun sequences of 23 biochemically indistinguishable clinical Shigella isolates
inferred← citeshttps://doi.org/10.1016/j.lanmic.2024.101064openalex-snapshot
Epidemiology of Shigella species and serotypes in children: a retrospective substudy of the MAL-ED observational birth cohort study
inferred← citeshttps://doi.org/10.1016/j.lwt.2021.112491openalex-snapshot
Photodynamic inactivation of Shigella flexneri by curcumin
inferred← citeshttps://doi.org/10.1016/j.meegid.2021.104922openalex-snapshot
Virulence profiling of Shigella flexneri and emergence of serotype 2b as a highly virulent shigellosis causing strain in Pakistan
inferred← citeshttps://doi.org/10.1016/j.micinf.2023.105100openalex-snapshot
A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice
inferred← citeshttps://doi.org/10.1016/j.molimm.2020.02.008openalex-snapshot
In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri
inferred← citeshttps://doi.org/10.1016/j.rmcr.2022.101645openalex-snapshot
The tale of the traveling cheese: Shigella in a lung transplant patient
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2020.142626openalex-snapshot
Spatiotemporal variations in the incidence of bacillary dysentery and long-term effects associated with meteorological and socioeconomic factors in China from 2013 to 2017
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2025.178401openalex-snapshot
Impact of water, sanitation, and hygiene indicators on enteric viral pathogens among under-5 children in low resource settings
inferred← citeshttps://doi.org/10.1016/j.tmaid.2016.05.006openalex-snapshot
Multi drug resistance and Extended Spectrum Beta Lactamases in clinical isolates of Shigella: A study from New Delhi, India
inferred← citeshttps://doi.org/10.1016/j.tmaid.2023.102554openalex-snapshot
Shigellosis in Southeast Asia: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.06.102openalex-snapshot
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
inferred← citeshttps://doi.org/10.1016/j.vaccine.2016.02.075openalex-snapshot
Status of vaccine research and development for Shigella
inferred← citeshttps://doi.org/10.1016/j.vaccine.2016.08.034openalex-snapshot
Development of recombinant vaccine candidate molecule against Shigella infection
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.07.036openalex-snapshot
Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.07.070openalex-snapshot
Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.09.083openalex-snapshot
Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.10.011openalex-snapshot
WHO consultation on ETEC and Shigella burden of disease, Geneva, 6–7th April 2017: Meeting report
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.09.052openalex-snapshot
Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.12.067openalex-snapshot
Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection
inferred← citeshttps://doi.org/10.1016/j.vaccine.2019.03.036openalex-snapshot
How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?
inferred← citeshttps://doi.org/10.1016/j.vaccine.2022.12.037openalex-snapshot
Vaccine value profile for Shigella
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.06.052openalex-snapshot
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.08.051openalex-snapshot
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.126263openalex-snapshot
Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge
inferred← citeshttps://doi.org/10.1016/j.vaccine.2025.126779openalex-snapshot
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128965openalex-snapshot
Qualification of a high-throughput luminescence-based Serum Bactericidal Activity assay to assess the functionality of human sera against five Shigella serotypes
inferred← citeshttps://doi.org/10.1016/s0140-6736(14)61789-xopenalex-snapshot
The extant World War 1 dysentery bacillus NCTC1: a genomic analysis
inferred← citeshttps://doi.org/10.1016/s0140-6736(16)31529-xopenalex-snapshot
Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study
inferred← citeshttps://doi.org/10.1016/s1473-3099(15)00002-xopenalex-snapshot
Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study
inferred← citeshttps://doi.org/10.1016/s1473-3099(18)30475-4openalex-snapshot
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016
inferred← citeshttps://doi.org/10.1016/s1473-3099(20)30488-6openalex-snapshot
Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study
inferred← citeshttps://doi.org/10.1016/s2214-109x(17)30392-3openalex-snapshot
Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/s2214-109x(22)00549-6openalex-snapshot
Spatiotemporal variation in risk of Shigella infection in childhood: a global risk mapping and prediction model using individual participant data
inferred← citeshttps://doi.org/10.1016/s2214-109x(23)00421-7openalex-snapshot
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries
inferred← citeshttps://doi.org/10.1016/s2214-109x(25)00534-0openalex-snapshot
The incidence and antimicrobial resistance of Shigella-attributable diarrhoea in young children in low-income and middle-income countries from the multicountry Enterics for Global Health (EFGH) Shigella Surveillance Study: a prospective, facility-based hybrid surveillance study
inferred← citeshttps://doi.org/10.1017/s0950268818000912openalex-snapshot
Shigella infection in children under 5 years old in western French Guiana
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.5b00617openalex-snapshot
A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity
inferred← citeshttps://doi.org/10.1021/acs.chemrev.0c01210openalex-snapshot
Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach
inferred← citeshttps://doi.org/10.1021/acs.joc.0c00777openalex-snapshot
Convergent Chemoenzymatic Strategy to Deliver a Diversity of Shigella flexneri Serotype-Specific O-Antigen Segments from a Unique Lightly Protected Tetrasaccharide Core
inferred← citeshttps://doi.org/10.1021/acs.joc.5b01407openalex-snapshot
Investigation on the Synthesis of Shigella flexneri Specific Oligosaccharides Using Disaccharides as Potential Transglucosylase Acceptor Substrates
inferred← citeshttps://doi.org/10.1021/acs.jpcb.0c01595openalex-snapshot
Effects of Glucosylation and O-Acetylation on the Conformation of Shigella flexneri Serogroup 2 O-Antigen Vaccine Targets
inferred← citeshttps://doi.org/10.1021/acscentsci.1c01479openalex-snapshot
The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella
inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00889openalex-snapshot
Target Product Profile and Development Path for Shigellosis Treatment with Antibacterials
inferred← citeshttps://doi.org/10.1021/bk-2018-1290.ch002openalex-snapshot
Glycoconjugate Vaccines: The Clinical Journey
inferred← citeshttps://doi.org/10.1021/bk-2018-1290.ch007openalex-snapshot
The Role of Molecular Modeling in Predicting Carbohydrate Antigen Conformation and Understanding Vaccine Immunogenicity
inferred← citeshttps://doi.org/10.1038/icb.2015.24openalex-snapshot
Shigella IpaB and IpaD displayed on L. lactis bacterium‐like particles induce protective immunity in adult and infant mice
inferred← citeshttps://doi.org/10.1038/nmicrobiol.2016.204openalex-snapshot
Deletion of toxin–antitoxin systems in the evolution of Shigella sonnei as a host-adapted pathogen
inferred← citeshttps://doi.org/10.1038/nrmicro.2016.10openalex-snapshot
The genomic signatures of Shigella evolution, adaptation and geographical spread
inferred← citeshttps://doi.org/10.1038/s41467-021-22700-4openalex-snapshot
Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonnei
inferred← citeshttps://doi.org/10.1038/s41467-023-43345-5openalex-snapshot
The genomic epidemiology of shigellosis in South Africa
inferred← citeshttps://doi.org/10.1038/s41467-025-64057-yopenalex-snapshot
Enhanced virulence and stress tolerance are signatures of epidemiologically successful Shigella sonnei
inferred← citeshttps://doi.org/10.1038/s41541-022-00497-7openalex-snapshot
Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens
inferred← citeshttps://doi.org/10.1038/s41541-023-00624-yopenalex-snapshot
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults
inferred← citeshttps://doi.org/10.1038/s41541-023-00725-8openalex-snapshot
A next-generation GMMA-based vaccine candidate to fight shigellosis
inferred← citeshttps://doi.org/10.1038/s41541-025-01305-8openalex-snapshot
Evaluation of cross-functional antibody responses elicited by a four-component GMMA Shigella vaccine
inferred← citeshttps://doi.org/10.1038/s41564-021-01054-zopenalex-snapshot
Pathogenomic analyses of Shigella isolates inform factors limiting shigellosis prevention and control across LMICs
inferred← citeshttps://doi.org/10.1038/s41579-024-01126-xopenalex-snapshot
Shigella sonnei: epidemiology, evolution, pathogenesis, resistance and host interactions
inferred← citeshttps://doi.org/10.1038/s41598-018-25764-3openalex-snapshot
Genomic epidemiology of Shigella in the United Kingdom shows transmission of pathogen sublineages and determinants of antimicrobial resistance
inferred← citeshttps://doi.org/10.1038/s41598-019-39810-1openalex-snapshot
Mutational convergence acts as a major player in adaptive parallel evolution of Shigella spp.
inferred← citeshttps://doi.org/10.1038/s41598-020-71754-9openalex-snapshot
Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults
inferred← citeshttps://doi.org/10.1038/s41598-021-81719-1openalex-snapshot
Redirecting substrate regioselectivity using engineered ΔN123-GBD-CD2 branching sucrases for the production of pentasaccharide repeating units of S. flexneri 3a, 4a and 4b haptens
inferred← citeshttps://doi.org/10.1038/s41598-021-92132-zopenalex-snapshot
Associated factors, post infection child growth, and household cost of invasive enteritis among under 5 children in Bangladesh
inferred← citeshttps://doi.org/10.1038/s41598-021-98910-zopenalex-snapshot
Morphological, biological, and genomic characterization of a newly isolated lytic phage Sfk20 infecting Shigella flexneri, Shigella sonnei, and Shigella dysenteriae1
inferred← citeshttps://doi.org/10.1038/s41598-021-99384-9openalex-snapshot
Computer-aided engineering of a branching sucrase for the glucodiversification of a tetrasaccharide precursor of S. flexneri antigenic oligosaccharides
inferred← citeshttps://doi.org/10.1038/s41598-024-59181-6openalex-snapshot
Field evaluation of a simple and rapid diagnostic test, RLDT to detect Shigella and enterotoxigenic E. coli in Indian children
inferred← citeshttps://doi.org/10.1039/c4cc08805kopenalex-snapshot
Programmed chemo-enzymatic synthesis of the oligosaccharide component of a carbohydrate-based antibacterial vaccine candidate
inferred← citeshttps://doi.org/10.1039/c6em00222fopenalex-snapshot
Environmental transmission of diarrheal pathogens in low and middle income countries
inferred← citeshttps://doi.org/10.1051/e3sconf/202560301015openalex-snapshot
Potential of a novel and thermostable recombinant phage endolysin of Escherichia phage KW1E_UTAR against Shigella spp.
inferred← citeshttps://doi.org/10.1074/jbc.m114.566570openalex-snapshot
Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications
inferred← citeshttps://doi.org/10.1080/19490976.2016.1239682openalex-snapshot
The synthesis of OspD3 (ShET2) inShigella flexneriis independent of OspC1
inferred← citeshttps://doi.org/10.1080/19490976.2020.1770666openalex-snapshot
Vaccines against gastroenteritis, current progress and challenges
inferred← citeshttps://doi.org/10.1080/19490976.2020.1795389openalex-snapshot
Research in a time of enteroids and organoids: how the human gut model has transformed the study of enteric bacterial pathogens
inferred← citeshttps://doi.org/10.1080/21505594.2023.2280838openalex-snapshot
Pathogenicity and virulence of Shigella sonnei : A highly drug-resistant pathogen of increasing prevalence
inferred← citeshttps://doi.org/10.1080/21645515.2019.1575165openalex-snapshot
A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children
inferred← citeshttps://doi.org/10.1080/21645515.2019.1578922openalex-snapshot
A roadmap for enterotoxigenic Escherichia coli vaccine development based on volunteer challenge studies
inferred← citeshttps://doi.org/10.1080/21645515.2019.1606971openalex-snapshot
Serum IgG antibodies to Shigella lipopolysaccharide antigens – a correlate of protection against shigellosis
inferred← citeshttps://doi.org/10.1080/21645515.2019.1606972openalex-snapshot
Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human
inferred← citeshttps://doi.org/10.1080/21645515.2025.2603736openalex-snapshot
Shigella sonnei and Shigella flexneri : Epidemiology supporting development of cross-protective vaccines
inferred← citeshttps://doi.org/10.1089/mdr.2016.0173openalex-snapshot
Genomic Analysis and Resistance Mechanisms in Shigella flexneri 2a Strain 301
inferred← citeshttps://doi.org/10.1093/cid/ciaa1545openalex-snapshot
The Clinical Presentation of Culture-positive and Culture-negative, Quantitative Polymerase Chain Reaction (qPCR)-Attributable Shigellosis in the Global Enteric Multicenter Study and Derivation of a Shigella Severity Score: Implications for Pediatric Shigella Vaccine Trials
inferred← citeshttps://doi.org/10.1093/cid/ciac969openalex-snapshot
Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
inferred← citeshttps://doi.org/10.1093/cid/ciu471openalex-snapshot
Editorial Commentary: A Shigella Vaccine Against Prevalent Serotypes
inferred← citeshttps://doi.org/10.1093/cid/ciz892openalex-snapshot
Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies
inferred← citeshttps://doi.org/10.1093/femsle/fnac020openalex-snapshot
Bacteriophage Sf6 host range mutant that infects Shigella flexneri serotype 2a2 strains
inferred← citeshttps://doi.org/10.1093/femspd/ftw027openalex-snapshot
Genome diversity of Shigella boydii
inferred← citeshttps://doi.org/10.1093/femspd/ftw034openalex-snapshot
Characterization of a multicomponent live, attenuatedShigella flexnerivaccine
inferred← citeshttps://doi.org/10.1093/femspd/ftw098openalex-snapshot
Stable expression ofShigella dysenteriaeserotype 1 O-antigen genes integrated into the chromosome of liveSalmonellaoral vaccine vector Ty21a
inferred← citeshttps://doi.org/10.1093/glycob/cwv077openalex-snapshot
Purification and characterization of aShigellaconjugate vaccine, produced by glycoengineeringEscherichia coli
inferred← citeshttps://doi.org/10.1093/glycob/cwz044openalex-snapshot
Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate
inferred← citeshttps://doi.org/10.1093/infdis/jiab462openalex-snapshot
Critical Needs in Advancing Shigella Vaccines for Global Health
inferred← citeshttps://doi.org/10.1093/infdis/jiag221openalex-snapshot
Shigella Vaccines: A Light at the End of a Long Tunnel
inferred← citeshttps://doi.org/10.1093/infdis/jiw528openalex-snapshot
Development of a live attenuated bivalent oral vaccine against Shigella sonnei shigellosis and typhoid fever
inferred← citeshttps://doi.org/10.1093/infdis/jiz220openalex-snapshot
Novel Insights Into the Spread of Enteric Pathogens Using Genomics
inferred← citeshttps://doi.org/10.1093/jpids/piv037openalex-snapshot
Failure of Syndrome-Based Diarrhea Management Guidelines to DetectShigellaInfections in Kenyan Children
inferred← citeshttps://doi.org/10.1093/jtm/taac132openalex-snapshot
Burden of Shigella in South Asia: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1093/jtm/tay049openalex-snapshot
Is a Shigella vaccine needed for travellers and the military?
inferred← citeshttps://doi.org/10.1093/lambio/ovac049openalex-snapshot
A novel strain of Shigella isolated from the gut of Lepidocephalichthys guntea has in its genome a complete gene package for Type ll secretion system, and elaborate repertoire of genes responsible for multiple antibiotic-resistance and metal resistance via specific efflux channels
inferred← citeshttps://doi.org/10.1093/ofid/ofad041openalex-snapshot
Salmonella Combination Vaccines: Moving Beyond Typhoid
inferred← citeshttps://doi.org/10.1093/ofid/ofad574openalex-snapshot
Shigella Detection and Molecular Serotyping With a Customized TaqMan Array Card in the Enterics for Global Health (EFGH): Shigella Surveillance Study
inferred← citeshttps://doi.org/10.1093/ofid/ofad576openalex-snapshot
Microbiological Methods Used in the Enterics for Global Health Shigella Surveillance Study
inferred← citeshttps://doi.org/10.1093/ofid/ofad653openalex-snapshot
The Enterics for Global Health (EFGH) Shigella Surveillance Study in Bangladesh
inferred← citeshttps://doi.org/10.1093/ofid/ofad654openalex-snapshot
The Enterics for Global Health (EFGH) Shigella Surveillance Study in Kenya
inferred← citeshttps://doi.org/10.1093/ofid/ofad664openalex-snapshot
Diarrhea Case Surveillance in the Enterics for Global Health Shigella Surveillance Study: Epidemiologic Methods
inferred← citeshttps://doi.org/10.1093/ofid/ofae003openalex-snapshot
The Enterics for Global Health (EFGH) Shigella Surveillance Study in Mali
inferred← citeshttps://doi.org/10.1093/ofid/ofae675openalex-snapshot
Development and Characterization of a 13-Plex Binding Assay to Detect Shigella Antibodies in Human Samples
inferred← citeshttps://doi.org/10.1093/ofid/ofaf026openalex-snapshot
Shigellosis in an Urban Slum in Kenya: Risk Factors and Antimicrobial Resistance
inferred← citeshttps://doi.org/10.1093/ofid/ofv134openalex-snapshot
Stx-Producing Shigella Species From Patients in Haiti: An Emerging Pathogen With the Potential for Global Spread
inferred← citeshttps://doi.org/10.1093/trstmh/tru175openalex-snapshot
Molecular characterization of Shigella spp. from patients in Gabon 2011-2013
inferred← citeshttps://doi.org/10.1097/mog.0000000000000133openalex-snapshot
An update on travelers’ diarrhea
inferred← citeshttps://doi.org/10.1097/mog.0000000000000136openalex-snapshot
Update on molecular epidemiology of Shigella infection
inferred← citeshttps://doi.org/10.1097/qco.0000000000000475openalex-snapshot
Recent insights into Shigella: a major contributor to the global diarrhoeal disease burden
inferred← citeshttps://doi.org/10.1097/qco.0000000000000758openalex-snapshot
Shigellosis in young children in low-income and middle-income countries: insights from molecular diagnostics
inferred← citeshttps://doi.org/10.1099/jmm.0.000779openalex-snapshot
Antimicrobial resistance profiles of Shigella dysenteriae isolated from travellers returning to the UK, 2004–2017
inferred← citeshttps://doi.org/10.1099/mgen.0.000311openalex-snapshot
Use of whole-genome sequencing to identify clusters of Shigella flexneri associated with sexual transmission in men who have sex with men in England: a validation study using linked behavioural data
inferred← citeshttps://doi.org/10.1099/mgen.0.000532openalex-snapshot
Whole genome sequence analysis of Shigella from Malawi identifies fluoroquinolone resistance
inferred← citeshttps://doi.org/10.1099/mgen.0.000704openalex-snapshot
Cluster-specific gene markers enhance Shigella and enteroinvasive Escherichia coli in silico serotyping
inferred← citeshttps://doi.org/10.1099/mgen.0.000736openalex-snapshot
The evolutionary history of Shigella flexneri serotype 6 in Asia
inferred← citeshttps://doi.org/10.1099/mgen.0.000846openalex-snapshot
Virulence plasmid pINV as a genetic signature for Shigella flexneri phylogeny
inferred← citeshttps://doi.org/10.1099/mgen.0.001157openalex-snapshot
Genomic analysis of Shigella isolates from Lebanon reveals marked genetic diversity and antimicrobial resistance
inferred← citeshttps://doi.org/10.1099/mgen.0.001838openalex-snapshot
Genomic epidemiology and antimicrobial resistance profile of Shigella isolated from diarrhoea diseases in under-five children in Blantyre, Malawi
inferred← citeshttps://doi.org/10.1101/2020.08.10.243006openalex-snapshot
The role of toxin:antitoxin systems and insertion sequences in the loss of virulence in Shigella sonnei
inferred← citeshttps://doi.org/10.1101/2021.03.09.434519openalex-snapshot
A comprehensive computational investigation into the conserved virulent proteins of Shigella sp unveils potential siRNA candidates as a new therapeutic strategy against shigellosis
inferred← citeshttps://doi.org/10.1101/2021.06.09.447709openalex-snapshot
Informing shigellosis prevention and control through pathogen genomics
inferred← citeshttps://doi.org/10.1101/2022.08.23.504947openalex-snapshot
Temporal GWAS identifies a widely distributed novel protein Stv contributing to pathogen success in Shigella spp
inferred← citeshttps://doi.org/10.1101/2022.09.26.22280249openalex-snapshot
Epidemiology and risk factors for diarrhoeagenic Escherichia coli carriage among children in northern Ibadan, Nigeria
inferred← citeshttps://doi.org/10.1101/2023.07.03.23292159openalex-snapshot
Burden of diarrhea and antibiotic use among children in low-resource settings preventable by Shigella vaccination: a simulation study
inferred← citeshttps://doi.org/10.1101/2023.08.24.554604openalex-snapshot
Targeted lipid A modification of Shigella vaccine strains reduced endotoxicity without compromising immunogenicity or invasiveness
inferred← citeshttps://doi.org/10.1101/2025.08.10.25333393openalex-snapshot
Population-based incidence and antimicrobial susceptibility patterns of shigellosis among children and adults from rural and urban Kenya, 2010-2019
inferred← citeshttps://doi.org/10.1101/799379openalex-snapshot
Shigella sonnei O-antigen inhibits internalisation, vacuole escape and inflammasome activation
inferred← citeshttps://doi.org/10.1111/1753-6405.12844openalex-snapshot
Culture‐positive shigellosis cases are epidemiologically different to culture‐negative/PCR‐positive cases
inferred← citeshttps://doi.org/10.1111/cmi.13067openalex-snapshot
A tale of two bacterial enteropathogens and one multivalent vaccine
inferred← citeshttps://doi.org/10.1111/cts.70453openalex-snapshot
Population Pharmacokinetic and Pharmacodynamic Prediction for Tebipenem Pivoxil Treatment of Pediatric Shigellosis
inferred← citeshttps://doi.org/10.1111/jam.15383openalex-snapshot
Development of a loop-mediated isothermal amplification assay for molecular serotyping of Shigella flexneri Serotypes 2 and Xv
inferred← citeshttps://doi.org/10.1111/lam.12690openalex-snapshot
Update on: Shigella new serogroups/serotypes and their antimicrobial resistance
inferred← citeshttps://doi.org/10.1111/tmi.13445openalex-snapshot
Pathogen‐specific risk of seizure in children with moderate‐to‐severe diarrhoea: Case control study with follow‐up
inferred← citeshttps://doi.org/10.1128/aem.00165-19openalex-snapshot
In Silico Serotyping Based on Whole-Genome Sequencing Improves the Accuracy of Shigella Identification
inferred← citeshttps://doi.org/10.1128/cmr.00008-21openalex-snapshot
Controlled Human Infection Models To Accelerate Vaccine Development
inferred← citeshttps://doi.org/10.1128/cvi.00148-16openalex-snapshot
Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production
inferred← citeshttps://doi.org/10.1128/cvi.00181-17openalex-snapshot
Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a
inferred← citeshttps://doi.org/10.1128/cvi.00224-16openalex-snapshot
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
inferred← citeshttps://doi.org/10.1128/cvi.00444-16openalex-snapshot
Shigella Vaccine Development: Finding the Path of Least Resistance
inferred← citeshttps://doi.org/10.1128/cvi.00608-15openalex-snapshot
Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects
inferred← citeshttps://doi.org/10.1128/cvi.00661-14openalex-snapshot
Shigella Outer Membrane Protein PSSP-1 Is Broadly Protective against Shigella Infection
inferred← citeshttps://doi.org/10.1128/ecosalplus.esp-0006-2017openalex-snapshot
A Brief History of Shigella
inferred← citeshttps://doi.org/10.1128/genomea.00393-15openalex-snapshot
Draft Genome Sequence of 24570, the Type Strain of Shigella flexneri
inferred← citeshttps://doi.org/10.1128/iai.00004-25openalex-snapshot
Immunogenicity and preclinical efficacy characterization of ShecVax, a combined vaccine against Shigella and enterotoxigenic Escherichia coli
inferred← citeshttps://doi.org/10.1128/iai.00316-23openalex-snapshot
A broadly immunogenic polyvalent Shigella multiepitope fusion antigen protein protects against Shigella sonnei and Shigella flexneri lethal pulmonary challenges in mice
inferred← citeshttps://doi.org/10.1128/iai.00665-25openalex-snapshot
Lithocholic acid induces T3SS-dependent formation of invasion-competent Shigella flexneri aggregates
inferred← citeshttps://doi.org/10.1128/iai.00740-18openalex-snapshot
Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model
showing the first 200 of 372 · page through all 372
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.